Literature DB >> 8707952

Chromosome 11q in sporadic colorectal carcinoma: patterns of allele loss and their significance for tumorigenesis.

I P Tomlinson1, W F Bodmer.   

Abstract

AIMS: To analyse the frequency of loss of heterozygosity (allele loss, LOH) in a large sample of colorectal carcinomas using highly informative markers along chromosome 11q.
METHODS: One hundred paired samples of colorectal cancer and normal tissue were genotyped at six microsatellite markers on chromosome 11q (cen-D11S1313-D11S901-DRD2/NCAM-D11S29- D11S968-tel). The high levels of heterozygosity at these markers allow allele loss to be determined in about 80% of cases at any one locus. The frequency of replication errors (RERs, microsatellite instability) has also been determined.
RESULTS: LOH was found at frequencies of 25% and 29% at the distal D11S968 (11qter) and D11S29 (11q23.3) loci, slightly above the accepted baseline of 0-20%. Allele loss at NCAM, DRD2, D11S901, and D11S1313 was not raised above baseline levels. The probable genetic mechanism of allele loss--chromosomal non-disjunction, mitotic recombination, deletion, or gene conversion--seemed to vary between tumours and no consistent mechanism of mutation was found. Microsatellite instability was found in 23 (23%) tumours. No associations were found between LOH and clinical data (patient sex, age at presentation, tumour site, and Duke's stage).
CONCLUSIONS: Although gene(s) on 11q may have a role in the development of a minority of colorectal carcinomas, this study provides evidence against the general importance of allele loss on chromosome 11q in the pathogenesis of colorectal cancer. The results also have implications for the importance of 11q in other cancers: it seems less likely that a single tumour supressor gene at this location promotes the growth of all types of tumour when lost. Rather, one or more genes with tissue specific effects may be involved.

Entities:  

Mesh:

Year:  1996        PMID: 8707952      PMCID: PMC500477          DOI: 10.1136/jcp.49.5.386

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  30 in total

1.  Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers.

Authors:  I P Tomlinson; A J Gammack; J E Stickland; G J Mann; R M MacKie; R F Kefford; J O McGee
Journal:  Genes Chromosomes Cancer       Date:  1993-07       Impact factor: 5.006

2.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

3.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

4.  Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma.

Authors:  Y Fujiwara; M Emi; H Ohata; Y Kato; T Nakajima; T Mori; Y Nakamura
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

5.  Genomic instability occurs in colorectal carcinomas but not in adenomas.

Authors:  J Young; B Leggett; C Gustafson; M Ward; J Searle; L Thomas; R Buttenshaw; G Chenevix-Trench
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

6.  [The expression of neural cell adhesion molecule (NCAM), neural invasion and recurrence patterns in rectal cancer--a study using anti-NACM (neural cell adhesion molecule) antibody].

Authors:  M Kenmotsu; A Gouchi; Y Maruo; N Murashima; Y Hiramoto; H Iwagaki; K Orita
Journal:  Nihon Geka Gakkai Zasshi       Date:  1994-02

7.  Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

Authors:  R A Lothe; P Peltomäki; G I Meling; L A Aaltonen; M Nyström-Lahti; L Pylkkänen; K Heimdal; T I Andersen; P Møller; T O Rognum
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

8.  Analysis of deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization.

Authors:  H Kobayashi; R Espinosa; A A Fernald; C Begy; M O Diaz; M M Le Beau; J D Rowley
Journal:  Genes Chromosomes Cancer       Date:  1993-12       Impact factor: 5.006

9.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.

Authors:  Y Ionov; M A Peinado; S Malkhosyan; D Shibata; M Perucho
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

10.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more
  5 in total

1.  Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.

Authors:  Y Takagi; M Futamura; K Yamaguchi; S Aoki; T Takahashi; S Saji
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

2.  Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q.

Authors:  Y Murakami; T Nobukuni; K Tamura; T Maruyama; T Sekiya; Y Arai; H Gomyou; A Tanigami; M Ohki; D Cabin; P Frischmeyer; P Hunt; R H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

3.  Genome-wide investigation of gene-environment interactions in colorectal cancer.

Authors:  Sabine Siegert; Jochen Hampe; Clemens Schafmayer; Witigo von Schönfels; Jan-Hendrik Egberts; Asta Försti; Bowang Chen; Jesús Lascorz; Kari Hemminki; Andre Franke; Michael Nothnagel; Ute Nöthlings; Michael Krawczak
Journal:  Hum Genet       Date:  2012-11-02       Impact factor: 4.132

4.  Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.

Authors:  I P Tomlinson; M Ilyas; W F Bodmer
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

5.  Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.

Authors:  A S Lee; Y C Seo; A Chang; S Tohari; K W Eu; F Seow-Choen; J O McGee
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.